New Penn-Designed Gel Allows for Targeted Therapy After Heart Attack

Combatting the tissue degrading enzymes that cause lasting damage following a heart attack is tricky. Each patient responds to a heart attack differently and damage can vary from one part of the heart muscle to another, but existing treatments can’t be fine-tuned to deal with this variation. 

Apolipoprotein(a) isoform size, lipoprotein(a) concentration, and coronary artery disease: a mendelian randomisation analysis - The Lancet Diabetes & Endocrinology

RETRACTED ARTICLE: Cross-HLA targeting of intracellular oncoproteins with peptide-centric CARs

Heterotrimeric G Proteins as Therapeutic Targets in Drug Discovery

Full article: Colorectal cancer management: strategies in drug delivery

Prospects and Therapeutic Applications of Cardiac Glycosides in Cancer Remediation

Drug and cell delivery for cardiac regeneration - ScienceDirect

tissue engineering – Penn Bioengineering Blog

Biologics and their delivery systems: Trends in myocardial infarction - ScienceDirect

Ligand-tethered lipid nanoparticles for targeted RNA delivery to treat liver fibrosis

Activation of Oxytocin Neurons Improves Cardiac Function in a Pressure-Overload Model of Heart Failure

Chimeric antigen receptor T cells as adjuvant therapy for unresectable adenocarcinoma